Objetivo
Cys-loop receptors (CLRs) form a superfamily of structurally related neurotransmitter-gated ion channels, comprising nicotinic acetylcholine, glycine, GABA-A/C and serotonin (5HT3) receptors, crucial to function of the peripheral and central nervous system. CLRs cover a wide spectrum of functions, ranging from muscle contraction to cognitive functions. CLR (mal)function is linked to various disorders, including muscular dystrophies, neurodegenerative diseases, e.g. Alzheimer’s and Parkinson’s, and neuropsychiatric diseases, e.g. schizophrenia, epilepsy and addiction. CLRs are potentially important drug targets for treatment of disease. However, novel drug discovery strategies call for in depth understanding of ligand binding sites, the structure-function relationships of these receptors and insight into their actions in the nervous system. NeuroCypres assembles the expertise of leading European laboratories to provide a technology workflow, which enables to embark on this next step in CLR structure and function. A major target of this project is to obtain high-resolution X-ray and NMR structures for CLRs and their complexes with diverse ligands, agonists/antagonists, channel blockers and modulators, which will reveal basic mechanisms of receptor functioning from ligand binding to gating and open new avenues to rational drug design. In addition, the project aims at understanding receptor function in the context of the brain, focusing on receptor biosensors, receptor-protein interactions and transgenic models. This major challenge requires application and development of a multidisciplinary workflow of high-throughput (HT) crystallization and HT-electrophysiology technologies, X-ray analysis, NMR and computational modeling, fragment-based drug design, innovative quantitative methods of interaction-proteomics, sensitive methods for visualization of activity and localization of receptors and studies of in vitro and in vivo function in animal models of disease.
Ámbito científico
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- medical and health sciencesbasic medicineneurologyepilepsy
- medical and health sciencesbasic medicineneurologymuscular dystrophies
- medical and health sciencesbasic medicinemedicinal chemistry
- medical and health sciencesclinical medicinepsychiatryschizophrenia
Palabras clave
Convocatoria de propuestas
FP7-HEALTH-2007-A
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-IP - Large-scale integrating projectCoordinador
1081 HV Amsterdam
Países Bajos
Ver en el mapa
Participantes (23)
1066 CX Amsterdam
Ver en el mapa
3000 Leuven
Ver en el mapa
91054 Erlangen
Ver en el mapa
CB2 1TN Cambridge
Ver en el mapa
1090 Wien
Ver en el mapa
75724 Paris
Ver en el mapa
117997 MOSCOW
Ver en el mapa
75654 Paris
Ver en el mapa
69117 Heidelberg
Ver en el mapa
WC1E 6BT LONDON
Ver en el mapa
La participación finalizó
1211 Geneve
Ver en el mapa
00185 Roma
Ver en el mapa
11521 Athens
Ver en el mapa
265 04 Rio Patras
Ver en el mapa
78464 Konstanz
Ver en el mapa
55129 MAINZ
Ver en el mapa
La participación finalizó
17455 ATHENS
Ver en el mapa
754 50 Uppsala
Ver en el mapa
1008 BA AMSTERDAM
Ver en el mapa
41121 Modena
Ver en el mapa
10561 Athina
Ver en el mapa
1211-12 GENEVE
Ver en el mapa
1081 HV Amsterdam
Ver en el mapa